Bellerophon Therapeutics, Inc(PINK:BLPH) 
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its products include INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hyper...
Website: http://www.bellerophon.com
Founded: 2009
Full Time Employees: 18
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-06-24
P
O 0.06
H 0.06
L 0.06
C 0.06
V 1,000
10EMA 0.06
20EMA 0.06
60EMA 0.06
120EMA 0.06
250EMA 0.06